Martha J. Demski
Independent DirectorMs. Martha J. Demski, MBA serves as Independent Director at Alpha Teknova, Inc. since August 31, 2023. She served as a Director of Adamas Pharmaceuticals, Inc. since March 4, 2014 until November 24, 2021. Ms. Demski served as Director at ADMA Biologics, Inc. until 2023. Ms. Demski served as Senior Vice President and Chief Financial Officer of Ajinomoto Althea, Inc. now known as Ajinomoto Bio-Pharma Service, since August 2011 until May 4, 2017 and served as its Secretary. Ms. Demski has experience in the fields of finance and biotechnology. She serves as a Director of Equillium, Inc. since September 2018. She served as Chief Financial Officer and Senior Vice President of Althea Technologies, Inc. from September 9, 2011 to April 2013 and served as its Interim Chief Financial Officer. She served as an Interim Chief Operating Officer and Chief Financial Officer of Sidney Kimmel Cancer Center (SKCC) from July 2008 to December 2010. She served as Chief Financial Officer of Vical Inc., from December 1988 to June 2004 and served as a Vice President, Treasurer and Secretary from December 1988 to June 2004. Since August 1977 until joining Vical Inc., Ms. Demski held various positions with Bank of America and served as its Vice President and Section Head of Technology Section. From April 2006 to May 2008, she served as Senior Vice President, U.S. Trust Division at Bank of America. She served as an Adviser to Bank of America on a statewide basis regarding the biotechnology industry in California. She served as Director of Evofem Biosciences, Inc. until January 17, 2018. She was an Independent Director of Neothetics, Inc. since July 2014. She was Chair of the Board of the biopharmaceutical company, Chimerix, Inc. since June 2018 until August 01, 2023 and served as its Independent Director since 2005 until April 21, 2025. She served as Lead Independent Director of Chimerix, Inc. since August 01, 2023 until April 21, 2025. From 2005 to July 2008, she served on the Board of Trustees of Sidney Kimmel Cancer Center. Ms. Demski is a National Association of Corporate Directors Board Governance Fellow. In 2017, she received the Director of the Year in Corporate Governance award by the Corporate Directors Forum. She has experience in the fields of finance and biotechnology as well as her experience as a Member of various boards of Directors. Ms. Demski received an MBA degree in Finance & Accounting from The University of Chicago Booth School of Business in 1977 and a BA degree in Education from the Michigan State University in 1974.
Positions
- Company NameEquillium, Inc.Stock CodeEQPositionIndependent DirectorColleagues
- BSBruce SteelCo-Founder, CEO & Director
- DMDaniel Mark BradburyChairman of the Board
- SCStephen ConnellyChief Scientific Officer & President
- CZChristine ZedelmayerSenior VP & COO
- PTPenny TomSenior VP of Finance & Principal Accounting Officer
- MMMichael MooreVice President of Investor Relations & Corporate Communications
- CMCharles McDermottIndependent Director
- MPMark PruzanskiIndependent Director
- Company NameAlpha Teknova, Inc.Stock CodeTKNOPositionIndependent DirectorColleagues
- SGStephen GunstreamPresident, CEO & Director
- PDPaul D. GrossmanChairman of the Board
- MCMatthew C. LowellChief Financial Officer
- DADamon A. TerrillGeneral Counsel, Chief Compliance Officer & Secretary
- JHJennifer HenrySenior Vice President of Marketing
- BMBrett M. RobertsonIndependent Director
- AVAlexander VosIndependent Director
- MJMartha J. DemskiIndependent Director
